Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 02, 2025

Get In Touch

SEC Asks Enzene Biosciences to Revise Phase III Trial Protocol for Nivolumab Biosimilar Pharma News

SEC Asks Enzene Biosciences to Revise Phase III Trial Protocol for Nivolumab Biosimilar

  • 12 October 2025
  • 3 weeks ago

Coldrif fallout: How a Pharma firm skipped India's Drug Watchdog inspections Pharma News

Coldrif fallout: How a Pharma firm skipped India's Drug Watchdog inspections

  • 11 October 2025
  • 3 weeks ago

CDSCO Panel seeks clarifications from Novo Nordisk on IcoSema phase IIIb clinical study protocol Pharma News

CDSCO Panel seeks clarifications from Novo Nordisk on IcoSema phase IIIb clinical study protocol

  • 11 October 2025
  • 3 weeks ago

CDSCO Orders Nationwide Audit of Cough Syrup Makers After Fatal Toxic Syrup Scare Pharma News

CDSCO Orders Nationwide Audit of Cough Syrup Makers After Fatal Toxic Syrup Scare

  • 11 October 2025
  • 3 weeks ago

CDSCO Panel Seeks More Safety Data from Raptim Research on Lenalidomide Patch Pharma News

CDSCO Panel Seeks More Safety Data from Raptim Research on Lenalidomide Patch

  • 11 October 2025
  • 3 weeks ago

3 cough syrups recalled, none exported: CDSCO responds to WHO Pharma News

3 cough syrups recalled, none exported: CDSCO responds to WHO

  • 11 October 2025
  • 3 weeks ago

Unequal Trials in New Drug Approvals: CDSCO Seeks Feedback for Policy Reform Pharma News

Unequal Trials in New Drug Approvals: CDSCO Seeks Feedback for Policy Reform

  • 10 October 2025
  • 3 weeks ago

Fludrocortisone 0.2 mg Study Rejected by CDSCO Panel Over Potential Adverse Effects Pharma News

Fludrocortisone 0.2 mg Study Rejected by CDSCO Panel Over Potential Adverse Effects

  • 10 October 2025
  • 3 weeks ago

No Entry Without Notice: CDSCO Directs All Drug Shipments Through Notified Ports via ICEGATE Pharma News

No Entry Without Notice: CDSCO Directs All Drug Shipments Through Notified Ports via ICEGATE

  • 10 October 2025
  • 3 weeks ago

AstraZeneca Gets SEC Nod for New Trastuzumab Deruxtecan Indication in HER2-Positive Solid Tumors Pharma News

AstraZeneca Gets SEC Nod for New Trastuzumab Deruxtecan Indication in HER2-Positive Solid Tumors

  • 10 October 2025
  • 3 weeks ago

Recent News

Himachal notifies Resident doctor policy 2025

  • 02 November, 2025

Pfizer files lawsuit against Metsera, its Director...

  • 02 November, 2025

Health Ministry achieves 3 Guinness World Records...

  • 02 November, 2025

Roche gets CE mark for Elecsys Dengue Ag test to d...

  • 02 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.